Skip to main content
. Author manuscript; available in PMC: 2014 Mar 13.
Published in final edited form as: Biochem Genet. 2009 Jun 30;47(0):688–693. doi: 10.1007/s10528-009-9266-y

Table 1. APOE genotypes in all-cause ESRD patients and healthy controls and odds ratios (95% confidence interval) for all-cause ESRD for the +APOE2 or +APOE4 allele carriers vs. APOE3E3 homozygotes.

Cases N (%) Controls N (%) Odds ratio (95% CI
+ APOE2 allele 158 (15.9%) 760 (12.2%) 1.37 (1.13-1.67)
APOE3E3 625 (62.8%) 4128 (66.1%) 1.0 (reference)
+ APOE4 allele 195 (19.6%) 1224 (21.7%) 1.05 (0.88-1.26)